Astrana Health (ASTH) Equity Income (2017 - 2026)

Astrana Health's Equity Income history runs 10 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Equity Income rose 298.39% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $4.3 million (up 44.51% YoY), while the FY2025 annual figure was $1.7 million, down 61.63% from the prior year.
• Equity Income came in at $1.7 million for Q1 2026 at Astrana Health, up from $1.2 million in the prior quarter.
• In the past five years, Equity Income ranged from a high of $2.7 million in Q2 2023 to a low of -$2.1 million in Q3 2023.
• A 5-year average of $1.1 million and a median of $1.4 million in 2024 frame the typical range for Equity Income.
• Across the five-year window, Equity Income surged 311.67% in 2022 and tumbled 244.9% in 2023, its largest moves.
• Astrana Health's Equity Income stood at $1.2 million in 2022, then soared by 102.04% to $2.5 million in 2023, then tumbled by 37.33% to $1.6 million in 2024, then retreated by 24.18% to $1.2 million in 2025, then soared by 46.26% to $1.7 million in 2026.
• According to Business Quant data, Equity Income over the past three periods registered $1.7 million, $1.2 million, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison